Pittenger & Anderson Inc’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.44M | Buy |
|
|||||
2025
Q1 | $3.91M | Sell |
|
|||||
2024
Q4 | $5.2M | Buy |
|
|||||
2024
Q3 | $6.81M | Sell |
|
|||||
2024
Q2 | $9.56M | Sell |
|
|||||
2024
Q1 | $8.85M | Sell |
|
|||||
2023
Q4 | $7.77M | Sell |
|
|||||
2023
Q3 | $7.99M | Sell |
|
|||||
2023
Q2 | $7.52M | Sell |
|
|||||
2023
Q1 | $8.08M | Sell |
|
|||||
2022
Q4 | $7.45M | Buy |
|
|||||
2022
Q3 | $4.67M | Buy |
|
|||||
2022
Q2 | $5.01M | Buy |
|
|||||
2022
Q1 | $4.97M | Buy |
|
|||||
2021
Q4 | $5.01M | Sell |
|
|||||
2021
Q3 | $4.31M | Hold |
|
|||||
2021
Q2 | $3.76M | Hold |
|
|||||
2021
Q1 | $3.03M | Hold |
|
|||||
2020
Q4 | $3.13M | Hold |
|
|||||
2020
Q3 | $3.12M | Buy |
|
|||||
2020
Q2 | $2.93M | Sell |
|
|||||
2020
Q1 | $2.71M | Buy |
|
|||||
2019
Q4 | $2.52M | Hold |
|
|||||
2019
Q3 | $2.25M | Buy |
|
|||||
2019
Q2 | $2.19M | Hold |
|
|||||
2019
Q1 | $2.25M | Buy |
|
|||||
2018
Q4 | $1.87M | Buy |
|
|||||
2016
Q4 | – | Sell |
|
|||||
2016
Q3 | $3.38M | Buy |
|
|||||
2016
Q2 | $3.75M | Buy |
|
|||||
2016
Q1 | $2.75M | Buy |
|
|||||
2015
Q4 | $2.85M | Buy |
|
|||||
2015
Q3 | $2.64M | Buy |
|
|||||
2015
Q2 | $2.57M | Buy |
|
|||||
2015
Q1 | $2.24M | Buy |
|
|||||
2014
Q4 | $1.76M | Buy |
|
|||||
2014
Q3 | $1.92M | Buy |
|
|||||
2014
Q2 | $1.86M | Buy |
|
|||||
2014
Q1 | $1.82M | Sell |
|
|||||
2013
Q4 | $1.5M | Buy |
|
|||||
2013
Q3 | $1.25M | Buy |
|
|||||
2013
Q2 | $1.05M | Buy |
|